$45.09
3.327.96%
Last update: Jul 14, 2:41 PM
10x Genomics Inc Earnings Estimates
TXGNASDAQ
PRO
10x Genomics Earnings Estimates, EPS & Revenue | NASDAQ:TXG
10x Genomics (TXG) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $146.68M.
In the most recent quarter (Q1), 10x Genomics reported EPS of $-0.10, meeting estimates of $-0.10. Revenue came in at $150.84M, exceeding the estimate of $146.38M by 0.03%.
Over the last 4 quarters, 10x Genomics has averaged an EPS surprise of 0.81% and a revenue surprise of 0.09%.
Earnings Date
Aug 6
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$146.68M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$638.78M
10x Genomics Earnings History
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
Loading calendar...
10x Genomics (TXG) Earnings Per Share
The chart below shows 10x Genomics's reported EPS compared to analyst estimates over recent quarters.
10x Genomics (TXG) Revenue
The chart below shows 10x Genomics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is 10x Genomics (NASDAQ:TXG) reporting earnings?
10x Genomics (TXG) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for 10x Genomics (NASDAQ:TXG)?
The Actual EPS was $-0.10, which hit the estimate of $-0.10.
What were 10x Genomics’s (NASDAQ:TXG) revenues?
The Actual Revenue was $150.84M, which beat the estimate of $146.38M.
